Problematic sexual arousal (PSA) is an umbrella term to describe a range of clinical presentations related to excessive sexual thinking (e.g., sexual preoccupation) and sexual behavior (e.g., hypersexuality). Although such concepts are known to affect sexual recidivism among individuals convicted of sexual offences, PSA is not routinely or directly targeted in offending behavior programs in England and Wales. However, in recent years, there have been moves to incorporate pharmacological interventions for addressing this among people with sexual offence histories. Although some work to understand the experiences of those taking SSRI medication for this purpose has emerged, little is known about the experiences of service users taking anti-androgen medication. In this study, we interviewed all individuals in prison taking anti-androgens for the treatment of problematic sexual arousal following convictions for sexual offences in England at the time of data collection (N = 10). Using a phenomenologically oriented thematic analysis, we established themes pertaining to “Differing needs: Motivations for treatment,” “Medication as a risk management strategy,” and how the medication helped the men in their pursuit of “Discovering a ‘new me’.” This work contributes important knowledge to inform the development of ethical and effective prescribing of anti-androgen medication with this population and offer recommendations for both future research and the development of clinical practice.

有问题的性唤起（PSA）是一个总称，描述与过度性思考（例如，性专注）和性行为（例如，性欲亢进）相关的一系列临床表现。尽管众所周知，这些概念会影响被定罪的性犯罪者的性累犯，但在英格兰和威尔士的犯罪行为计划中，PSA 并不是常规或直接的目标。然而，近年来，已经采取措施纳入药物干预措施，以解决有性犯罪史的人的这一问题。尽管已经出现了一些了解为此目的服用 SSRI 药物的人的经历的工作，但人们对服用抗雄激素药物的服务使用者的经历知之甚少。在这项研究中，我们采访了在数据收集时英格兰因性犯罪被定罪后服用抗雄激素治疗有问题的性唤起的监狱中的所有个人（N  = 10）。通过以现象学为导向的主题分析，我们建立了有关“不同需求：治疗动机”、“药物作为风险管理策略”以及药物如何帮助男性追求“发现‘新的我’”的主题。这项工作提供了重要的知识，为该人群制定合乎道德且有效的抗雄激素药物处方提供信息，并为未来的研究和临床实践的发展提供建议。